deltatrials
Terminated PHASE3 NCT00547274

Dyslipidemia in Type 2 Diabetes (0767-034)

Sponsor: Merck Sharp & Dohme LLC

Conditions Diabetes Mellitus, Type II Dyslipidemia
Interventions MK0767
Updated 6 times since 2017 Last updated: Jun 11, 2015 Started: Jul 31, 2003 Primary completion: Nov 30, 2003 Completion: Nov 30, 2003

Listed as NCT00547274, this PHASE3 trial focuses on Diabetes Mellitus, Type II and Dyslipidemia and remains terminated or withdrawn. Sponsored by Merck Sharp & Dohme LLC, it has been updated 6 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Jun 2022 — Jul 2024 [monthly]

    Terminated PHASE3

  4. Jan 2021 — Jun 2022 [monthly]

    Terminated PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE3

    First recorded

Jul 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Merck Sharp & Dohme LLC
Data source: Merck Sharp & Dohme LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.